´ëÀå¾Ï 3±â(Stage III Colon Cancer) ¼ºº°°ú Á¾¾çÀ§Ä¡¿¡ µû¸¥ ¹«º´»ýÁ¸À²(Disease-free survival) Â÷ÀÌ
Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection
2018³â¿¡ ¹ßÇ¥µÈ Á߾Ӿϵî·Ïº»ºÎ ÀÚ·á¿¡ ÀÇÇϸé 2016³â¿¡ ¿ì¸®³ª¶ó¿¡¼´Â 229,180°ÇÀÇ ¾ÏÀÌ »õ·ÎÀÌ ¹ß»ýÇߴµ¥, ±×Áß ´ëÀå¾Ï(C18~C20)Àº ³²³à¸¦ ÇÕÃÄ 28,127°ÇÀ¸·Î ÀüüÀÇ 12.3%·Î 2À§¸¦ Â÷ÁöÇß´Ù. Àα¸ 10¸¸ ¸í´ç Á¶(ðØ)¹ß»ý·ü(ÇØ´ç °üÂû ±â°£ Áß ´ë»ó Àα¸ Áý´Ü¿¡¼ »õ·Ó°Ô ¹ß»ýÇÑ È¯ÀÚ ¼ö. Á¶»ç¸Á·üµµ »êÃâ ±âÁØÀÌ µ¿ÀÏ)Àº 55.0°ÇÀ̾ú´Ù. ³²³àÀÇ ¼ººñ´Â 1.5 : 1·Î ³²ÀÚ¿¡°Ô ´õ ¸¹ÀÌ ¹ß»ýÇßÀ½À» º¸°íÇß´Ù. Åë°èÇÐÀû ¹ß»ý°Ç¼ö´Â ³²ÀÚ°¡ 16,672°ÇÀ¸·Î ³²¼ºÀÇ ¾Ï Áß 3À§, ¿©ÀÚ´Â 11,455°ÇÀ¸·Î ¿©¼ºÀÇ ¾Ï Áß 3À§·Î º¸°íµÇ°í ÀÖ´Ù. ±×·¯³ª 2003³âºÎÅÍ 2011³â»çÀÌ, 8³âµ¿¾ÈÀÇ ÄÚȣƮ ºÐ¼®¿¡¼´Â ´ëÀå¾Ï 3±âÀÎ °æ¿ì ¿©¼º¿¡°Ô¼ ¹«º´»ýÁ¸À²ÀÌ ´õ ³·°Ô º¸°íµÇ¾ú´Ù. ÇÑÆí ¿¬·ÉÀº ´ëÀå¾Ï ¹ß»ýºóµµ¿Í ºñ·ÊÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç, ¿¬·ÉÀÌ ³ôÀ»¼ö·Ï ƯÈ÷ 50¼¼ ÀÌ»óÀÎ °æ¿ì ´ëÀå¾Ï ¹ß»ýÀ§ÇèÀÌ °¡Àå ³ô°í, ¿¬·Éº° ºÐÆ÷·Î´Â ³²³à¸¦ ÇÕÃÄ 70´ë°¡ 26.6%·Î °¡Àå ¸¹¾Ò°í, 60´ë°¡ 26.5%, 50´ë°¡ 21.2%ÀÇ ¼øÀ̾ú´Ù.
[±Ù°Å±â¹Ý ÀÓ»óÁú¹®-´äº¯]
Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection
ÀÓ»óÁú¹®
|
´ëÀå¾Ï 3±âȯÀÚ¿¡¼ ¼ºº°°ú Á¾¾çÀ§Ä¡¿¡ µû¶ó ¹«º´»ýÁ¸À²(disease-free survival, DFS)¿¡ Â÷ÀÌ°¡ ÀÖ³ª¿ä?
|
±Ù°Å±â¹Ý ´äº¯
|
Stage IIIC ´ëÀå¾ÏÀº ¿©¼º ȯÀÚ¿¡¼ ¹ß»ýÇßÀ» ¶§, ±×¸®°í ¿ìÃø Á¾¾çÀ§Ä¡, lymph node ratio (LNR)ÀÌ ³ôÀ» ¶§ Á¾¾çÇÐÀû ¿¹ÈÄ´Â ÁÁÁö ¾Ê½À´Ï´Ù.
|
¼ÁöÁ¤º¸
|
Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection (2018). Annals of Coloproctology, 34(6), p.286 ~ 291
|
¿¬±¸¸ñÀû
|
Stage IIIC ´ëÀå¾Ï ȯÀÚÀÇ DFSÀÇ ¿¹ÃøÀÎÀÚ¸¦ °áÁ¤Çϱâ À§ÇÔ
|
¿¬±¸¼³°è
|
2003³â~ 2011³â ÈÄÇâÀû ÄÚȣƮ ¿¬±¸¼³°è
|
¿¬±¸´ë»ó
|
N=611: ´ëÀå¾Ï 3±â(stage-IIIC colon adenocarcinoma)Áø´ÜÀ» ¹ÞÀº ´ëÀå¾ÏȯÀÚ Áß Ä¡·áÀû ÀýÁ¦¼úÀ» ¹ÞÀº ȯÀÚ (³²¼º 355¸í vs. ¿©¼º 256¸í)
|
½ÃÇ豺 ÁßÀç
|
¿ìÃø´ëÀå¾Ï(right-sided colon cancer, RCC), n=213
|
´ëÁ¶±º ÁßÀç
|
ÁÂÃø ´ëÀå¾Ï(left-sided colon cancer, LCC), n=398
|
Æò°¡ÁöÇ¥
|
¹«º´»ýÁ¸À²(disease-free survival, DFS)
|
ÁÖ¿ä°á°ú
|
´ëÀå¾ÏÀÇ 3Â÷¿¹¹æ(Tertiary prevention) °üÁ¡¿¡¼´Â º´ÀÌ ÁøÇàµÈ ȯÀÚ¸¦ ´ë»óÀ¸·Î ´õ ÀÌ»óÀÇ ¾ÇÈ¿Í ÇÕº´Áõ ¹× ÈÄÀ¯ÁõÀÇ ¹ß»ýÀ» ¸·°í ÀçÈ°Ä¡·á¿Í ÀÚ±â°ü¸® µîÀ» ÅëÇØ ½Åü±â´ÉÀÇ À¯Áö¿Í »îÀÇ Áú Çâ»óÀ» µµ¸ðÇÏ´Â Á¶Ä¡ µîÀÌ ÇÊ¿äÇÏ´Ù. Ưº°È÷ ´ëÀå¾Ï 3±â Áø´ÜÀ» ¹ÞÀº ¼ºº°ÀÌ ¿©¼ºÀÎ °æ¿ì¿Í Á¾¾çÀÇ À§Ä¡°¡ ¿ìÃøÀÎ °áÀå¾Ï ȯÀÚ¿¡¼ Á» ´õ ³ôÀº Á¾¾ç Àç¹ß·ü°ú DFSÀÇ ³ª»Û ¿¹ÈÄ°¡ º¸°íµÇ¾ú´Ù. ÀÌ ±×·ìÀÇ È¯ÀÚ¿¡°Ô´Â Àû±ØÀûÀÎ Ä¡·á¿Í ¹ÐÁ¢ÇÑ °ü¸®°¡ °èȹµÇ¾î¾ßÇÑ´Ù.
|
±Ù°Å¼öÁØ
|
Moderate
|
ÀÛ¼ºÀÚ
|
±¹°¡ÁöÁ¤ ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC)
Copyright © 2015. Medical Research Information Center (MedRIC) Editors
|